Forsta AP Fonden cut its position in shares of CME Group Inc. (NASDAQ:CME) by 17.8% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 457,893 shares of the financial services provider’s stock after selling 99,100 shares during the period. CME Group makes up about 1.6% of Forsta AP Fonden’s holdings, making the stock its 8th largest position. Forsta AP Fonden owned about 0.13% of CME Group worth $57,347,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Huntington National Bank boosted its stake in CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares in the last quarter. Coconut Grove Bank boosted its stake in CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock valued at $107,000 after buying an additional 440 shares in the last quarter. Whittier Trust Co. boosted its stake in CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock valued at $122,000 after buying an additional 115 shares in the last quarter. Parallel Advisors LLC boosted its stake in CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after buying an additional 43 shares in the last quarter. Finally, RidgeWorth Capital Management LLC boosted its stake in CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock valued at $135,000 after buying an additional 406 shares in the last quarter. 83.25% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Inc. (NASDAQ CME) traded up 0.02% on Friday, reaching $125.39. 1,048,291 shares of the company traded hands. The stock has a market capitalization of $42.62 billion, a price-to-earnings ratio of 25.60 and a beta of 0.73. The firm has a 50 day moving average price of $123.50 and a 200 day moving average price of $121.16. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $127.96.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. During the same period in the previous year, the company earned $1.14 earnings per share. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities research analysts predict that CME Group Inc. will post $4.80 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Thursday, September 7th. CME Group’s dividend payout ratio is presently 53.99%.
Several research firms have issued reports on CME. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 price target on shares of CME Group in a research note on Friday, July 14th. UBS AG reiterated a “buy” rating and set a $134.00 price objective (down from $136.00) on shares of CME Group in a report on Monday, June 5th. BidaskClub lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Finally, Deutsche Bank AG cut their price objective on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $131.63.
In other CME Group news, Chairman Terrence A. Duffy sold 21,815 shares of the company’s stock in a transaction on Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total value of $2,702,660.35. Following the sale, the chairman now directly owns 110,711 shares in the company, valued at $13,715,985.79. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy S. Bitsberger sold 800 shares of the company’s stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $125.93, for a total value of $100,744.00. Following the completion of the sale, the director now owns 9,024 shares in the company, valued at $1,136,392.32. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 91,085 shares of company stock worth $11,242,896. 0.61% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.